Intracellular Lipopolysaccharide Sensing as a Potential Therapeutic Target for Sepsis
-
Published:2019-03
Issue:3
Volume:40
Page:187-197
-
ISSN:0165-6147
-
Container-title:Trends in Pharmacological Sciences
-
language:en
-
Short-container-title:Trends in Pharmacological Sciences
Author:
Pfalzgraff Anja,
Weindl GüntherORCID
Subject
Pharmacology,Toxicology
Reference92 articles.
1. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors;Kawai;Nat. Immunol.,2010
2. Signal transduction by the lipopolysaccharide receptor, toll-like receptor-4;Palsson-McDermott;Immunology,2004
3. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial;Opal;JAMA,2013
4. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis;Rice;Crit. Care Med.,2010
5. Non-canonical activation of inflammatory caspases by cytosolic LPS in innate immunity;Yang;Curr. Opin. Immunol.,2015
Cited by
107 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献